290 related articles for article (PubMed ID: 32058840)
1. Changing attitudes toward maggot debridement therapy in wound treatment: a review and discussion.
King C
J Wound Care; 2020 Feb; 29(Sup2c):S28-S34. PubMed ID: 32058840
[TBL] [Abstract][Full Text] [Related]
2. Maggot debridement therapy and complementary wound care: a case series from Nigeria.
Yusuf MA; Ibrahim BM; Oyebanji AA; Abubakar F; Ibrahim M; Ibrahim Jalo R; Aminu A; Akbarzadeh K; Azam M; Sheshe AA; Ganiyu OO; Abubakar MK; Salisu WJ; Kordshouli RS; Adamu AY; Takalmawa H; Daneji I; Aliyu M; Ibrahim MG; Kabuga AI; Abdullahi AS; Abbas MA
J Wound Care; 2022 Nov; 31(11):996-1005. PubMed ID: 36367805
[TBL] [Abstract][Full Text] [Related]
3. [Maggot therapy in wound management].
Falch BM; de Weerd L; Sundsfjord A
Tidsskr Nor Laegeforen; 2009 Sep; 129(18):1864-7. PubMed ID: 19844278
[TBL] [Abstract][Full Text] [Related]
4. [Maggots of Lucilia sericata in treatment of intractable wounds].
Orkiszewski M
Wiad Lek; 2007; 60(7-8):381-5. PubMed ID: 18175560
[TBL] [Abstract][Full Text] [Related]
5. Maggot debridement therapy to treat hard-to-heal diabetic foot ulcers: a single-centre study.
Nair HK; Ahmad NW; Ismail AA; Alabed AAA; Zheming BO; Kaur G; Hassan H; Supaat NI
J Wound Care; 2021 Dec; 30(Sup12):S30-S36. PubMed ID: 34882006
[TBL] [Abstract][Full Text] [Related]
6. Acceleration of cutaneous wound healing by Lucilia sericata maggots in diabetic Wistar rats.
Borkataki S; Katoch R; Goswami P; Bhat A; Chakraborty D
Trop Biomed; 2021 Mar; 38(1):86-93. PubMed ID: 33797529
[TBL] [Abstract][Full Text] [Related]
7. Towards next generation maggot debridement therapy: transgenic Lucilia sericata larvae that produce and secrete a human growth factor.
Linger RJ; Belikoff EJ; Yan Y; Li F; Wantuch HA; Fitzsimons HL; Scott MJ
BMC Biotechnol; 2016 Mar; 16():30. PubMed ID: 27006073
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Maggot Therapy on Staphylococcus aureus and Pseudomonas aeruginosa in Diabetic Foot Ulcers: A Randomized Controlled Trial.
Malekian A; Esmaeeli Djavid G; Akbarzadeh K; Soltandallal M; Rassi Y; Rafinejad J; Rahimi Foroushani A; Farhoud A; Bakhtiary R; Totonchi M
J Wound Ostomy Continence Nurs; 2019; 46(1):25-29. PubMed ID: 30608337
[TBL] [Abstract][Full Text] [Related]
9. Maggot debridement therapy with Lucilia cuprina: a comparison with conventional debridement in diabetic foot ulcers.
Paul AG; Ahmad NW; Lee HL; Ariff AM; Saranum M; Naicker AS; Osman Z
Int Wound J; 2009 Feb; 6(1):39-46. PubMed ID: 19291114
[TBL] [Abstract][Full Text] [Related]
10. The role of medical-grade maggots in facilitating healing of diabetic foot ulcers in Kano, northern Nigeria: a case series.
Yusuf MA; Ibrahim BM; Abubakar F; Ibrahim M; Sheshe AA; Abubakar MK; Aji SA; Gbadamasi KA; Busayo JK; Sallau SB; Ridwan BA; Uloko AE; Gezawa ID; Ramalan M; Sidi K; Abdullahi S; Adamu KM; Bello N; Muhammad A; Mukhtar R; Aina D
J Wound Care; 2024 Feb; 33(Sup2):S24-S30. PubMed ID: 38348863
[TBL] [Abstract][Full Text] [Related]
11. Maggot debridement therapy in chronic wound care.
Chan DC; Fong DH; Leung JY; Patil NG; Leung GK
Hong Kong Med J; 2007 Oct; 13(5):382-6. PubMed ID: 17914145
[TBL] [Abstract][Full Text] [Related]
12. [Biosurgical débridement using Lucilia sericata-maggots - an update].
Nenoff P; Herrmann A; Gerlach C; Herrmann J; Simon JC
Wien Med Wochenschr; 2010 Dec; 160(21-22):578-85. PubMed ID: 20714816
[TBL] [Abstract][Full Text] [Related]
13. Advantages of Maggot Debridement Therapy for Chronic Wounds: A Bibliographic Review.
Moya-López J; Costela-Ruiz V; García-Recio E; Sherman RA; De Luna-Bertos E
Adv Skin Wound Care; 2020 Oct; 33(10):515-525. PubMed ID: 32941225
[TBL] [Abstract][Full Text] [Related]
14. Phantom pain as an adverse effect after maggot (
Lipiński P; Trzciński R; Dziki Ł; Mik M
J Wound Care; 2020 May; 29(5):303-305. PubMed ID: 32421481
[TBL] [Abstract][Full Text] [Related]
15. Reappraisal and updated review of maggot debridement therapy in chronic lower extremity ulcers.
Shamloul G; Khachemoune A
Int J Dermatol; 2023 Jul; 62(7):962-968. PubMed ID: 36880424
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism of maggot debridement therapy in promoting wound angiogenesis in patients with diabetic foot ulcer].
Wang TY; Chen YC; Wang W; Jiang D; Liu L; Yang H; Wang AP
Zhonghua Shao Shang Za Zhi; 2020 Nov; 36(11):1040-1049. PubMed ID: 33238687
[No Abstract] [Full Text] [Related]
17. The use of maggot debridement therapy in the treatment of chronic wounds in hospitalised and ambulatory patients.
Gilead L; Mumcuoglu KY; Ingber A
J Wound Care; 2012 Feb; 21(2):78, 80, 82-85. PubMed ID: 22584527
[TBL] [Abstract][Full Text] [Related]
18. Clinical research on the bio-debridement effect of maggot therapy for treatment of chronically infected lesions.
Wang SY; Wang JN; Lv DC; Diao YP; Zhang Z
Orthop Surg; 2010 Aug; 2(3):201-6. PubMed ID: 22009949
[TBL] [Abstract][Full Text] [Related]
19. [Maggot therapy for gangrene and osteomyelitis].
Mumcuoglu KY; Lipo M; Ioffe-Uspensky I; Miller J; Galun R
Harefuah; 1997 Mar; 132(5):323-5, 382. PubMed ID: 9153871
[TBL] [Abstract][Full Text] [Related]
20. Clinical and microbiological efficacy of MDT in the treatment of diabetic foot ulcers.
Tantawi TI; Gohar YM; Kotb MM; Beshara FM; El-Naggar MM
J Wound Care; 2007 Oct; 16(9):379-83. PubMed ID: 17987750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
